Micro-Imaging of Amyloid in Mice

Methods in Enzymology

Volumn 412, Issue , 2006, Pages 161-182

  Wall, Jonathan S ^a   Paulus, Michael J ^a   Gleason, Shaun ^a   Gregor, Jens ^a   Solomon, Alan ^a   Kennel, Stephen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; IODINE 125; RADIOACTIVE IODINE; RADIOISOTOPE; TRACER;

AMYLOIDOSIS; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EQUIPMENT; EXPERIMENTAL MOUSE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR IMAGING; NEUROANATOMY; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RADIOIODINATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; X RAY ANALYSIS;

AMYLOID; AMYLOIDOSIS; ANIMALS; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, TRANSGENIC; SERUM AMYLOID P-COMPONENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

ANIMALIA; MURINAE;

EID: 33749642854     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)12011-X     Document Type: Review

References (65)

1. Abe M., Goto T., Kennel S.J., Wolfenbarger D., Macy S.D., Weiss D.T., and Solomon A. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. Am. J. Clin. Pathol. 100 (1993) 67-74
2. Abe M., Goto T., Wolfenbarger D., Weiss D.T., and Solomon A. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups. Hybridoma. 12 (1993) 475-483
3. Auf dem Brinke D., Kohrle J., Kodding R., and Hesch R.D. Subcellular localization of thyroxine-5-deiodinase in rat liver. J. Endocrinol. Invest. 3 (1980) 73-76
4. Axelrad M.A., Kisilevsky R., Willmer J., Chen S.J., and Skinner M. Further characterization of amyloid-enhancing factor. Lab. Invest. 47 (1982) 139-146
5. Bailey G.S. Labeling of peptides and proteins by radioiodination. Methods Mol. Biol. 32 (1994) 441-448
6. Behr T.M., Gotthardt M., Becker W., and Behe M. Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience. Nuklearmedizin. 41 (2002) 71-79
7. Bellotti V., Mangione P., and Merlini G. Review: Immunoglobulin light chain amyloidosis-the archetype of structural and pathogenic variability. J. Struct. Biol. 130 (2000) 280-289
8. Bishop G.M., and Robinson S.R. Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease. Drugs Aging 21 (2004) 621-630
9. Bolton A.E., and Hunter W.M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem. J. 133 (1973) 529-539
10. Caspi D., Zalzman S., Baratz M., Teitelbaum Z., Yaron M., Pras M., Baltz M.L., and Pepys M.B. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component. Arthritis Rheum. 30 (1987) 1303-1306
11. Cummings J.L. Alzheimer's disease. N. Engl. J. Med. 351 (2004) 56-67
12. De Beer F.C., and Pepys M.B. Isolation of human C-reactive protein and serum amyloid P component. J. Immunol. Methods 50 (1982) 17-31
13. De Nardo G.L., De Nardo S.J., Miyao N.P., Mills S.L., Peng J.S., O'Grady L.F., Epstein A.L., and Young W.C. Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies. Int. J. Biol. Markers 3 (1988) 1-9
14. Fattori E., Della Rocca C., Costa P., Giorgio M., Dente B., Pozzi L., and Ciliberto G. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83 (1994) 2570-2579
15. Feldkamp L.A., Davis L.C., and Kress J.W. Practical cone-beam algorithm. J. Opt. Soc. Am. 1 (1984) 612-619
16. Garg S., Garg P.K., Zhao X.G., Friedman H.S., Bigner D.D., and Zalutsky M.R. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Nucl. Med. Biol. 20 (1993) 835-842
17. Ghetti B., Tagliavini F., Takao M., Bugiani O., and Piccardo P. Hereditary prion protein amyloidoses. Clin. Lab. Med. 23 (2003) 65-85 viii
18. Gregor J., Gleason S.S., Kennel S.J., Paulus M.J., Benson T., and Wall J.S. Approximate volumetric system models for microSPECT. "Proc. IEEE Nuclear Science Symposium and Medical Imaging Conference" (2004) 4 Rome, Italy
19. Gregor J., Gleason S.S., Paulus M.J., and Cates J. Fast Feldkamp reconstruction based on focus of attention and distributed computing. Int. J. Imaging Syst. Technol. 12 (2002) 229-234
20. Hawkins P.N. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr. Opin. Nephrol. Hypertens. 11 (2002) 649-655
21. Hawkins P.N., Myers M.J., Epenetos A.A., Caspi D., and Pepys M.B. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J. Exp. Med. 167 (1988) 903-913
22. Hawkins P.N., Myers M.J., Epenetos A.A., Caspi D., and Pepys M.B. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J. Exp. Med. 167 (1988) 903-913
23. Hawkins P.N., Myers M.J., Lavender J.P., and Pepys M.B. Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component. Lancet 1 (1988) 1413-1418
24. Hnatowich D.J. Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium. Semin. Nucl. Med. 20 (1990) 80-91
25. Hrncic R., Wall J., Wolfenbarger D.A., Murphy C.L., Schell M., Weiss D.T., and Solomon A. Antibody-mediated resolution of light chain-associated amyloid deposits [In Process Citation]. Am. J. Pathol. 157 (2000) 1239-1246
26. Hudson H.M., and Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans. Med. Imaging 13 (1994) 601-609
27. Hull R.L., Westermark G.T., Westermark P., and Kahn S.E. Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 89 (2004) 3629-3643
28. Inoue S., and Kisilevsky R. In situ electron microscopy of amyloid deposits in tissues. Methods Enzymol. 309 (1999) 496-509
29. Jain A.K. "Fundamentals of Digital Image Processing." (1989), Pearson Prentice-Hall, Englewood Cliffs, N.J
30. Karonen S.L. Developments in techniques for radioiodination of peptide hormones and other proteins. Scand. J. Clin. Lab. Invest. Suppl. 201 (1990) 135-138
31. Kennel S.J., Falcioni R., and Wesley J.W. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res. 51 (1991) 1529-1536
32. Kindy M.S., and de Beer F.C. A mouse model for serum amyloid A amyloidosis. Methods Enzymol. 309 (1999) 701-716
33. Kisilevsky R., Lemieux L.J., Fraser P.E., Kong X., Hultin P.G., and Szarek W.A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nat. Med. 1 (1995) 143-148
34. Kisilevsky R., Szarek W.A., Ancsin J.B., Elimova E., Marone S., Bhat S., and Berkin A. Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: Implications for the treatment of various amyloidoses. Am. J. Pathol. 164 (2004) 2127-2137
35. Kohrle J., Rasmussen U.B., Ekenbarger D.M., Alex S., Rokos H., Hesch R.D., and Leonard J.L. Affinity labeling of rat liver and kidney type I 5′-deiodinase. Identification of the 27-kDa substrate binding subunit. J. Biol. Chem. 265 (1990) 6155-6163
36. Kovalchuk A.L., Kim J.S., Park S.S., Coleman A.E., Ward J.M., Morse III H.C., Kishimoto T., Potter M., and Janz S. IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc. Natl. Acad. Sci. USA 99 (2002) 1509-1514
37. Koziorowski J., Henssen C., and Weinrich R. A new convenient route to radioiodinated N-succinimidyl 3- and 4-iodobenzoate, two reagents for radioiodination of proteins. Appl. Radiat. Isot. 49 (1998) 955-959
38. MacRaild C.A., Stewart C.R., Mok Y.F., Gunzburg M.J., Perugini M.A., Lawrence L.J., Tirtaatmadja V., Cooper-White J.J., and Howlett G.J. Non-fibrillar components of amyloid deposits mediate the self-association and tangling of amyloid fibrils. J. Biol. Chem. 279 (2004) 21038-21125
39. Marshall J., McNally W., Muller D., Meincken G., Fand I., Srivastava S.C., Atkins H., Wood D.D., and Gorevic P.D. In vivo radioimmunodetection of amyloid deposits in experimental amyloidosis. In: Glenner G.G., Osserman E.F., Benditt E.P., Calkins E., Cohen A.S., and Zucker-Franklin D. (Eds). "Amyloidosis" (1986), Plenum Press, NY 163-174
40. McConahey P.J., and Dixon F.J. A method of trace iodination of proteins for immunologic studies. Int. Arch. Allergy Appl. Immunol. 29 (1966) 185-189
41. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349 (2003) 583-596
42. Mihara M., Shiina M., Nishimoto N., Yoshizaki K., Kishimoto T., and Akamatsu K. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis. J. Rheumatol. 31 (2004) 1132-1138
43. O'Nuallain B., Murphy C.L., Wolfenbarger D.A., Kennel S.J., Solomon A., and Wall J.S. The amyloid-reactive monoclonal antibody 11-1F4 binds a cryptic epitope on fibrils and partially denatured immunoglobulin light chains and inhibits fibrillogenesis. In: Grateau G., Kyle R.A., and Skinner M. (Eds). "Amyloid and Amyloidosis: Proceedings of the Xth International Symposium on Amyloidosis" (2005), CRC Press, Tours, France 482-484
44. Paulus M.J., Gleason S.S., Easterly M.E., and Foltz C.J. A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. Lab. Anim. (NY) 30 (2001) 36-45
45. Paulus M.J., Gleason S.S., Kennel S.J., Hunsicker P.R., and Johnson D.K. High resolution X-ray computed tomography: An emerging tool for small animal cancer research. Neoplasia 2 (2000) 62-70
46. Paulus M.J., Gleason S.S., Sari-Sarraf H., Johnsosn D.K., Foltz C.J., Austin D.W., Easterly M.E., Michaud E.J., Dhar M.S., Hunsicker P.R., Wall J.S., and Schell M. High-resolution X-ray CT screening of mutant mouse models. "BIOS 2000 International Biomedical Optics Symposium" (2000), San Jose, Calif
47. Paulus M.J., Sari-Sarraf H., Gleason S.S., Bobrek M., Hicks J.S., Johnson D.B., Behel J.K., Thompson L.H., and Allen W.C. A new x-ray computed tomography system for laboratory mouse imaging. IEEE Trans. Nucl. Sci. 46 (1999) 558-564
48. Pepys M.B., Booth D.R., Hutchinson W.L., Gallimore J.R., Collins P.M., and Hohenester E. Amyloid P component. A critical review. Amyloid Int. J. Exp. Clin. Invest. 4 (1997) 274-295
49. Pras M., Schubert M., Zucker-Franklin D., Rimon A., and Franklin E.C. The characterization of soluble amyloid prepared in water. J. Clin. Invest. 47 (1968) 924-933
50. Rocken C., and Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch. 440 (2002) 111-122
51. Shepp L.A., and Vardi Y. Maximum-likelihood reconstruction for emission tomography. IEEE Trans. Med. Imaging 1 (1982) 113-122
52. Snow A.D., and Kisilevsky R. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study. Lab. Invest. 53 (1985) 37-44
53. Solomon A., Weiss D.T., and Wall J.S. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies. Cancer Biother. Radiopharm. 18 (2003) 853-860
54. Solomon A., Weiss D.T., and Wall J.S. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin. Cancer Res. 9 (2003) 3831S-3838S
55. Spanka M., Hesch R.D., Irmscher K., and Kohrle J. 5′-Deiodination in rat hepatocytes: Effects of specific flavonoid inhibitors. Endocrinology 126 (1990) 1660-1667
56. Stenstad T., and Husby G. Brefeldin A inhibits experimentally induced AA amyloidosis. J. Rheumatol. 23 (1996) 93-100
57. Vaidyanathan G., Affleck D., Welsh P., Srinivasan A., Schmidt M., and Zalutsky M.R. Radioiodination and astatination of octreotide by conjugation labeling. Nucl. Med. Biol. 27 (2000) 329-337
58. Vaidyanathan G., and Zalutsky M.R. Protein radiohalogenation: Observations on the design of N-succinimidyl ester acylation agents. Bioconjug. Chem. 1 (1990) 269-273
59. Vaidyanathan G., and Zalutsky M.R. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates. Bioconjug. Chem. 1 (1990) 387-393
60. Wall J., Schell M., Hrncic R., Macy S.D., Wooliver C., Wolfenbarger D.A., Murphy C., Donnell R., Weiss D.T., and Solomon A. Treatment of Amyloidosis using an anti-fibril monoclonal antibody: Preclinical efficacy in a murine model of AA-amyloidosis. In: Bely M. (Ed). "Amyloid and Amyloidosis: Proceedings of the IXth International Symposium on Amyloidosis" (2001), David Apathy, Budapest, Hungary 158-160
61. Wall J.S., Kennel S.J., Paulus M.J., Gleason S., Gregor J., Baba J., Schell M., Richey T., O'Nuallain B., Donnell R., Hawkins P.N., Weiss D.T., and Solomon A. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA-amyloidosis. Amyloid J. Protein Folding Disord. 12 (2005) 149-156
62. Wall J.S., Paulus M.J., Kennel S.J., Gleason S., Baba J., Gregor J., Wolfenbarger D.A., Weiss D.T., and Solomon A. Radioimaging of primary (AL) amyloidosis with an amyloid-reactive monoclonal antibody. In: Grateau G., Kyle R.A., and Skinner M. (Eds). "Amyloid and Amyloidosis: Proceedings of the Xth International Symposium on Amyloidosis" (2005), CRC Press, Tours, France 37-39
63. Westermark G.T., Johnson K.H., and Westermark P. Staining methods for identification of amyloid in tissue. Methods Enzymol. 309 (1999) 3-25
64. Wilbur D.S. Radiohalogenation of proteins: An overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjug. Chem. 3 (1992) 433-470
65. Zhu H., Yu J., and Kindy M.S. Inhibition of amyloidosis using low-molecular-weight heparins. Mol. Med. 7 (2001) 517-522